Epstein-Barr viruses (EBVs) deficient in EBV-encoded RNAs have higher levels of latent membrane protein 2 RNA expression in lymphoblastoid cell lines and efficiently establish persistent infections in humanized mice

Journal of Virology

Volumn 89, Issue 22, 2015, Pages 11711-11714

  Gregorovic, Goran ^a   Boulden, Elizabeth A ^a   Bosshard, Rachel ^a   Karstegl, Claudio Elgueta ^a   Skalsky, Rebecca ^b,d   Cullen, Bryan R ^b   Gujer, Cornelia ^c   Rämer, Patrick ^c   Münz, Christian ^c   Farrell, Paul J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ENCODED RNA; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; MICRORNA; PROTEIN P53; RIBOSOMAL PROTEIN L22; RIBOSOME PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA; CISPLATIN; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; EPSTEIN-BARR VIRUS ENCODED RNA 1; EPSTEIN-BARR VIRUS ENCODED RNA 2; MATRIX PROTEIN; RNA BINDING PROTEIN; RPL22 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL LEVEL; CELLULAR IMMUNITY; CYTOPLASM; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE DELETION; GENE EXPRESSION; HEMATOPOIETIC SYSTEM; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS STRAIN; WILD TYPE; ANIMAL; BIOSYNTHESIS; CELL LINE; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; SCID MOUSE;

ANIMALS; CELL LINE; CISPLATIN; HERPESVIRUS 4, HUMAN; HUMANS; MICE; MICE, KNOCKOUT; MICE, SCID; MICRORNAS; RIBOSOMAL PROTEINS; RNA, VIRAL; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; VIRAL MATRIX PROTEINS;

EID: 84945898810     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01873-15     Document Type: Article

References (18)

1. Gregorovic G, Bosshard R, Karstegl CE, White RE, Pattle S, Chiang AK, Dittrich-Breiholz O, Kracht M, Russ R, Farrell PJ. 2011. Cellular gene expression that correlates with EBER expression in Epstein-Barr virusinfected lymphoblastoid cell lines. J Virol 85:3535-3545. http://dx.doi.org/10.1128/JVI.02086-10.
2. Toczyski DP, Matera AG, Ward DC, Steitz JA. 1994. The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. Proc Natl Acad Sci U S A 91:3463-3467. http://dx.doi.org/10.1073/pnas.91.8.3463.
3. Anderson SJ, Lauritsen JPH, Hartman MG, Foushee AMD, Lefebvre JM, Shinton SA, Gerhardt B, Hardy RR, Oravecz T, Wiest DL. 2007. Ablation of ribosomal protein L22 selectively impairs [alpha][beta] T cell development by activation of a p53-dependent checkpoint. Immunity 26: 759-772. http://dx.doi.org/10.1016/j.immuni.2007.04.012.
4. Fahl SP, Harris B, Coffey F, Wiest DL. 2015. Rpl22 loss impairs the development of B lymphocytes by activating a p53-dependent checkpoint. J Immunol 194:200-209. http://dx.doi.org/10.4049/jimmunol.1402242.
5. Rashkovan M, Vadnais C, Ross J, Gigoux M, Suh WK, Gu W, Kosan C, Moroy T. 2014. Miz-1 regulates translation of Trp53 via ribosomal protein L22 in cells undergoing V(D)J recombination. Proc Natl Acad Sci U S A 111:E5411-E5419. http://dx.doi.org/10.1073/pnas.1412107111.
6. Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, Hafner M, Nusbaum JD, Feederle R, Delecluse HJ, Luftig MA, Tuschl T, Ohler U, Cullen BR. 2012. The viral and cellular micro RNA targetome in lymphoblastoid cell lines. PLoS Pathog 8:e1002484. http://dx.doi.org/10.1371/journal.ppat.1002484.
7. Chen SJ, Chen GH, Chen YH, Liu CY, Chang KP, Chang YS, Chen HC. 2010. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One 5:e12745. http://dx.doi.org/10.1371/journal.pone.0012745.
8. Skalsky RL, Kang D, Linnstaedt SD, Cullen BR. 2014. Evolutionary conservation of primate lymphocryptovirus microRNA targets. J Virol 88:1617-1635. http://dx.doi.org/10.1128/JVI.02071-13.
9. Cramer EM, Shao Y, Wang Y, Yuan Y. 2014. miR-190 is upregulated in Epstein-Barr virus type I latency and modulates cellular mRNAs involved in cell survival and viral reactivation. Virology 464-465:184-195.
10. Lee N, Moss WN, Yario TA, Steitz JA. 2015. EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA. Cell 160:607-618. http://dx.doi.org/10.1016/j.cell.2015.01.015.
11. Gujer C, Chatterjee B, Landtwing V, Raykova A, McHugh D, Munz C. 2015. Animal models of Epstein Barr virus infection. Curr Opin Virol 13:6-10. http://dx.doi.org/10.1016/j.coviro.2015.03.014.
12. Iwakiri D, Zhou L, Samanta M, Matsumoto M, Ebihara T, Seya T, Imai S, Fujieda M, Kawa K, Takada K. 2009. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 206:2091-2099. http://dx.doi.org/10.1084/jem.20081761.
13. Ahmed W, Philip PS, Tariq S, Khan G. 2014. Epstein-Barr virusencoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells. PLoS One 9:e99163. http://dx.doi.org/10.1371/journal.pone.0099163.
14. Friedländer MR, Mackowiak SD, Li N, Chen W, Rajewsky N. 2012. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res 40:37-52. http://dx.doi.org/10.1093/nar/gkr688.
15. Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139-140. http://dx.doi.org/10.1093/bioinformatics/btp616.
16. Robinson MD, Oshlack A. 2010. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 11:R25. http://dx.doi.org/10.1186/gb-2010-11-3-r25.
17. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108. http://dx.doi.org/10.1038/nprot.2008.73.
18. Antsiferova O, Muller A, Ramer PC, Chijioke O, Chatterjee B, Raykova A, Planas R, Sospedra M, Shumilov A, Tsai MH, Delecluse HJ, Munz C. 2014. Adoptive transfer of EBV specific CD8+T cell clones can transiently control EBV infection in humanized mice. PLoS Pathog 10:e1004333. http://dx.doi.org/10.1371/journal.ppat.1004333.